Biotech China 2014
Biomarkers Europe
InterContinental Wien
1037 Vienna, Austria
Vienna,
http://www.healthtech.com/bme/overview.aspx?C=581

Schedule of Presentations:

Monday, November 10, 2008
08:00:00 Conference Registration and Morning Coffee
09:00:00 Welcoming Remarks from Conference Director
09:10:00 Chairperson’s Opening Remarks
09:15:00 Translational Strategies to Turn Pre-Clinical Information to Decision Making Early Clinical Studies Håkan Wennbo
09:45:00 Personalized Healthcare and Biomarker Strategies: Lost in Translation Stefan Scherer
10:15:00 Coffee Break with Poster and Exhibit Viewing
11:00:00 In Silico Biomarker Discovery Frank Schacherer
11:15:00 Pharmacodynamic Biomarkers in Early Phase Clinical Research Rosalyn Forsey
11:30:00 Improving Analysis of in vivo Angiogenesis: Objective Measurement of Microvessel Density in Tumors & Tissues
11:45:00 Biomarkers Predicting Clinical Benefit: Fact or Fiction? Hans Winkler
12:15:00 Lunch on your own
14:00:00 Allelic Expression in Human Blood from a Depression Case/Control Collection: Assessing the Functional Impact of SNPs on a Genome-Wide Scale for the Identification of Novel Genetic-Driven Biomarkers Enrico Domenici
14:30:00 Biomarkers of Health Martin Grigorov
15:00:00 Refreshment Break with Poster and Exhibit Viewing
15:45:00 From Protein Biomarker Discovery to Validation in Clinical Samples Hanno Langen
16:15:00 Integrated Molecular Profiling Approaches Towards Biomarker Discovery in Neuroscience Alain J. van Gool
Tuesday, November 11, 2008
08:00:00 Roundtable Discussions with Coffee and Continental Breakfast
09:00:00 Chairperson’s Opening Remarks
09:05:00 Waypoints vs. Endpoints: Fitting Biomarkers to Purpose with the Regulatory Authorities Linda Surh
09:35:00 Biomarkers and Pharmacogenomics; A Regulatory Perspective Krishna Prasad
10:05:00 Coffee Break with Poster and Exhibit Viewing
11:00:00 Ongoing Qualification of Cardiac Troponin Measurements within Preclinical Safety Assessment: Case-Study Driven Approach Malcolm York
11:30:00 Experimental Medicine and Marker Endpoints in Orphan Disease: The Motor Neuron Disease Example Vincenzo Libri
12:00:00 Post-Conference Short Course - FIT-FOR-PURPOSE BIOMARKER ASSAY DEVELOPMENT AND VALIDATION John L. Allinson
12:00:00 Influence of Bcl-2 Family Members on the Cellular Response to ABT-263, a Novel and Potent BH-3 Mimetic Stephen K. Tahir
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.